Characterization of human cultured periosteal sheets expressing bone-forming potential: In vitro and in vivo animal studies

Journal of Tissue Engineering and Regenerative Medicine

Volumn 3, Issue 3, 2009, Pages 218-229

  Kawase, Tomoyuki ^a   Okuda, Kazuhiro ^a   Kogami, Hiroyuki ^a   Nakayama, Hitoshi ^a,b   Nagata, Masaki ^a   Nakata, Koh ^c   Yoshie, Hiromasa ^a  

^a NIIGATA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Bone regeneration; Differentiation; Implantation; Osteoblast; Periostium; Tissue engineering

Indexed keywords

ALKALINITY; BIOMATERIALS; BONE; HYDROXYAPATITE; OSTEOBLASTS; PHOSPHATASES; SCAFFOLDS (BIOLOGY);

ANIMAL STUDIES; BONE REGENERATION; CYTOKINES; DIFFERENTIATION; IMPLANTATION; IMPLANTATION SITES; IN-VITRO; PERIOSTIUM; TISSUES ENGINEERINGS; VITRO AND IN VIVO;

TISSUE REGENERATION;

ALKALINE PHOSPHATASE; BIOMATERIAL; CULTURED PERIOSTEAL SHEET; HYDROXYAPATITE; INTERLEUKIN 13; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 2; THROMBOPOIETIN; UNCLASSIFIED DRUG; CALCIUM; CYTOKINE; PARAFFIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCHEMISTRY; BONE MINERALIZATION; CELL GROWTH; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; OSSIFICATION; OSTEOBLAST; OSTEOID; PERIOSTEUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE CULTURE; TISSUE DIFFERENTIATION; TISSUE STRUCTURE; ANIMAL; BONE DEVELOPMENT; CELL CULTURE; CELL PROLIFERATION; CELL SHAPE; CYTOLOGY; ENZYMOLOGY; METABOLISM; NUDE MOUSE; PROTEOMICS; REGENERATIVE MEDICINE; SECRETION; TIME;

ADULT; ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; CELL PROLIFERATION; CELL SHAPE; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; MALE; MICE; MICE, NUDE; MODELS, ANIMAL; OSTEOGENESIS; PARAFFIN; PERIOSTEUM; PROTEOMICS; REGENERATIVE MEDICINE; TIME FACTORS;

EID: 67649206397     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.156     Document Type: Article

References (27)

1. Calvert JW, Lefer DJ. 2008; Thrombopoietin emerges as a new haematopoietic cytokine that confers cardioprotection against acute myocardial infarction. Cardiovasc Res 77: 2-3.
2. Cooper LF, Uoshima K. 1994; Differential estrogenic regulation of small Mr heat shock protein expression in osteoblasts. J Biol Chem 269: 7869-7873.
3. Cornish J, Callon KE, Edgar SG, et al. 1997; Leukemia inhibitory factor is mitogenic to osteoblasts. Bone 21: 243-247.
4. Gadient RA, Patterson PH. 1999; Leukemia inhibitory factor, interleukin 6, and other cytokines using the GP130 transducing receptor: role in inflammation and injury. Stem Cells 17: 127-137.
5. Garrido C, Bruey JM, Fromentin A, et al. 1999; HSP27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 13: 2061-2070.
6. Guénal I, Sidoti-de Fraisse C, Gaumer S, et al. 1997; Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene 15: 347-360.
7. Hammarström L, Heijl L, Gestrelius S. 1997; Periodontal regeneration in a buccal dehiscence model in monkeys after application of enamel matrix proteins. J Clin Peridontol 24: 669-677.
8. Karpatkin S. 2005; Cytokine GRO-α is pivotal in thrombin-induced angiogenesis. Haematol Rep 1: 25-26.
9. Kawase T, Okuda K, Yoshie H, et al. 2000; Cytostatic action of enamel matrix derivative (EMDOGAIN) on human oral squamous cell carcinoma-derived SCC25 epithelial cells. J Periodont Res 35: 291-300.
10. Kawase T, Okuda K, Momose M, et al. 2001; Enamel matrix derivative (EMDOGAIN) rapidly stimulates phosphorylation of the MAP kinase family and nuclear accumulation of smad2 in both oral epithelial and fibroblastic human cells. J Periodont Res 36: 367-376.
11. Kawase T, Okuda K, Yoshie H, et al. 2002; Anti-TGFβ antibody blocks enamel matrix derivative-induced upregulation of p21WAF1/cip1 and prevents its inhibition of human oral epithelial cell proliferation. J Periodont Res 37: 255-262.
12. Kristensen DB, Imamura K, Miyamoto Y, et al. 2000; Mass spectrometric approaches for the characterization of proteins on a hybrid quadrupole time-of-flight (Q-TOF) mass spectrometer. Electrophoresis 21: 430-439.
13. Linkhart TA, Mohan S, Baylink DJ. 1996; Growth factors for bone growth and repair: IGF, TGFβ and BMP. Bone 19: 1S-12S.
14. Lowe C, Cornish J, Callon K, et al. 1991; Regulation of osteoblast proliferation by leukemia inhibitory factor. J Bone Miner Res 6: 1277-1283.
15. Lopez MF, Berggren K, Chernokalskaya E, et al. 2000; A comparison of silver stain and SYPRO ruby protein gel stain with respect to protein detection in two-dimensional gels and identification by peptide mass profiling. Electrophoresis 21: 3673-3683.
16. Matsuo K, Irie N. 2008; Osteoclast-osteoblast communication. Arch Biochem Biophys 473: 201-209.
17. Mizuno H, Hata KI, Kojima K, et al. 2006; A novel approach to regenerating periodontal tissue by grafting autologous cultured periosteum. Tissue Eng 12: 1227-335.
18. Manolagas SC. 1995; Role of cytokines in bone resportion. Bone 17: S 63-67.
19. Okuda K, Yamamiya K, Kawase T, et al. 2009; Treatment of human infrabony periodontal defects by grafting human cultured periosteum sheets combined with platelet-rich plasma and porous hydroxyapatite granules: case series. J Int Acad Periodontol (in press).
20. Peter SJ, Liang CR, Kim DJ, et al. 1998; Osteoblastic phenotype of rat marrow stromal cells cultured in the presence of dexamethasone, β-glycerol phosphate 3, and L-ascorbic acid. J Cell Biochem 71: 55-62.
21. Rabilloud T, Valette C, Lawrence JJ. 1994; Sample application by in-gel rehydration improves the resolution of two-dimensional electrophoresis with immobilized pH gradients in the first dimension. Electrophoresis 15: 1552-1558.
22. Sanchez JC, Rouge V, Pisteur M, et al. 1997; Improved and simplified in-gel sample application using reswelling of dry immobilized pH gradients. Electrophoresis 18: 324-327.
23. Seeman E. 2003; Reduced bone formation and increased bone resorption: rational targets for the treatment of osteoporosis. Osteoporos Int 14(suppl 3): S2-8.
24. Tenenbaum HC, Heersche JN. 1985; Dexamethasone stimulates osteogenesis in chick periosteum in vitro. Endocrinology 117: 2211-2217.
25. Yamagata A, Kristensen DB, Takeda Y, et al. 2002; Mapping of phosphorylated proteins on two-dimensional polyacrylamide gels using protein phosphatase. Proteomics 2: 1267-1276.
26. Yamamiya K, Okuda K, Kawase T, et al. 2008; Tissue-engineered human cultured periosteum sheets combined with platelet-rich plasma and porous hydroxyapatite graft in treating human periodontal infrabony osseous defects: a comparative controlled clinical study. J Periodontol 79: 811-818.
27. Yoshitake F, Itoh S, Narita H, et al. 2008; Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κB signaling pathways. J Biol Chem 283: 11535-11540.